Pages that link to "Q36490048"

The following pages link to Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule (Q36490048):

Displaying 48 items.

• Clinical epidemiology of epithelial ovarian cancer in the UK (Q26822648) (← links)
• In 2014, can we do better than CA125 in the early detection of ovarian cancer? (Q26825152) (← links)
• Ovarian cancer screening--current status, future directions (Q27004471) (← links)
• Challenging and complex decisions in the management of the BRCA mutation carrier (Q27026559) (← links)
• Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population (Q28266112) (← links)
• Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199. (Q30370475) (← links)
• Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women (Q33848119) (← links)
• Features of ovarian cancer in Lynch syndrome (Review). (Q34268630) (← links)
• Prophylactic bilateral salpingectomy as a prevention strategy in women at high-risk of ovarian cancer: a mini-review (Q34407218) (← links)
• Leveraging biospecimen resources for discovery or validation of markers for early cancer detection (Q35127253) (← links)
• A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care (Q35736066) (← links)
• Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer (Q36276527) (← links)
• Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act. (Q36313479) (← links)
• Identifying post-menopausal women at elevated risk for epithelial ovarian cancer (Q36331643) (← links)
• Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers (Q36372283) (← links)
• Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO). (Q36893991) (← links)
• Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer (Q36894026) (← links)
• Opportunistic salpingectomy for ovarian cancer prevention (Q36938143) (← links)
• Clinical Efficacy of Ovarian Cancer Screening. (Q37068015) (← links)
• Epigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells (Q37260961) (← links)
• Ovarian carcinoma in situ of presumable fallopian tube origin in a patient with Lynch syndrome: A case report (Q37390307) (← links)
• Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer. (Q37620476) (← links)
• Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers (Q38175815) (← links)
• Vibrational spectroscopy of biofluids for disease screening or diagnosis: translation from the laboratory to a clinical setting (Q38197570) (← links)
• Should the annual pelvic examination go the way of annual cervical cytology? (Q38254648) (← links)
• Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice (Q38367226) (← links)
• Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials (Q38988184) (← links)
• Personalised Medicine Approaches to Screening and Prevention (Q40197199) (← links)
• Development of an integrated support system for hereditary cancer and its impact on gynecologic services. (Q43749121) (← links)
• A qualitative study of women's experiences of familial ovarian cancer screening (Q43898763) (← links)
• Is attendance at an ovarian cancer screening clinic a worry-reducing event? Findings from pre- to post-screening (Q45134867) (← links)
• The sex hormone system in carriers of BRCA1/2 mutations: a case-control study. (Q45802281) (← links)
• Impact of a decision aid about stratified ovarian cancer risk-management on women's knowledge and intentions: a randomised online experimental survey study. (Q46139318) (← links)
• Influences on anticipated time to ovarian cancer symptom presentation in women at increased risk compared to population risk of ovarian cancer (Q47119680) (← links)
• BRCA and lynch syndrome-associated ovarian cancers behave differently (Q47183577) (← links)
• Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study. (Q47368363) (← links)
• Outcome of elevated CA125 values from primary care following implementation of ovarian cancer guidelines (Q47610637) (← links)
• Psychological morbidity associated with ovarian cancer screening: results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS). (Q47870813) (← links)
• Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study. (Q47958061) (← links)
• A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention. (Q51744236) (← links)
• Is routine adnexal scanning for postmenopausal bleeding of value? Observational study of 2101 women. (Q53305000) (← links)
• Ovarian cancer (Q54105461) (← links)
• Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision. (Q54956851) (← links)
• Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations (Q57688855) (← links)
• The Chemoprevention of Ovarian Cancer: the Need and the Options (Q58579152) (← links)
• Selected medical interventions in women with a deleterious mutation: a population-based study in British Columbia (Q64256332) (← links)
• A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results (Q89654302) (← links)
• Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations (Q94325832) (← links)